<DOC>
	<DOCNO>NCT00850421</DOCNO>
	<brief_summary>The purpose study ass whether subject treat BOTOX : 1. decrease frequency intensity migraine headaches 2. experience improvement quality life 3. experience reduction frequency health care service obtain .</brief_summary>
	<brief_title>Pilot Study BOTOX Migraine Headaches</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subjects &gt; 18 year age Subject establish history migraine headache , without aura , per IHS criterion ( 1.2.1 1.1 ) , least 6 month prior screen . Subject receive primary health care Park Nicollet Health Services . Subject receive previous injection botulinum toxin serotype reason , within 6 month prior study participation . Additional eligibility discuss point contact</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>migraine headache</keyword>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>BOTOX</keyword>
	<keyword>BTX-A</keyword>
</DOC>